MedTrace Logo

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

NCT06141135 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2025-08-26

No results posted yet for this study

Summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Conditions

  • Infertility, Female

Interventions

OTHER

Preimplantation genetic testing for aneuploidy (PGTA)

24 chromosome screening for aneuploidy in the preimplantation embryo(blastocyst stage)

Sponsors & Collaborators

  • Boston IVF

    collaborator OTHER

  • Genomic Prediction Inc.

    lead INDUSTRY

Principal Investigators

  • Nathan Treff, PhD · Genomic Prediction Clinical Labortory

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-15
Primary Completion
2025-11-15
Completion
2026-11-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06141135 on ClinicalTrials.gov